Category: Health & Medicines > Health Care Supplement > Human Growth Hormon
Country/Region: South Korea
Main Products: Erythropoietin, Human Growth Hormone, Dengue NS1, Ceftriaxone, Erythropoietin
Business Type: Manufacturer
Business Nature: Manufacturer
Year Established: 2012, 2012
Legal Status: Agency
Ownership: Corporation Limited Liability Company
Employees: 201 - 300 People
Factory Size: 30, 000-50, 000 square meters
R&D Team Size: 11 - 50 People
Certifications: ISO/TS16949
Contact Person: Youngha Jung
Designation: Account Manager
Department: M/D
Telephone: 82-1022610158
Main Markets: United States (28%) Mexico (28%) South Korea (24%) United Kingdom (23%) Netherlands (13%) Australia (12%)
Export Focus: Australia, South Korea, Mexico, Netherlands, United Kingdom, United States
Contract Services: Buyer Label Offered
Annual Revenue: Approx More Than 1 Billion US Dollar
Registered Capital: US$10 Million - US$50 Million
Export Percentage: 1% - 10%
Payment Terms: Bank wire (T/T), Letter of Credit (L/C), Western Union (WU), Cash